Home/Specialties/Gastroenterology
Revenue management for gastroenterologyWas That a Screening or a Diagnostic Procedure? Your Record Has to Say.
The scope does not know the difference. The same procedure, performed the same way by the same physician, is a screening test or a diagnostic one depending on why the patient was there and what was already documented about their history. That distinction sets how often the test may be furnished, what the practice is paid, and what the patient owes. It is decided by facts recorded before the procedure, not by what happened during it.
Start with the free CareVixis practice assessment. No email required.
The Scope Does Not Know.
The same procedure is a screening test or a diagnostic one depending on why the patient came.
Nothing about the instrument or the technique distinguishes them.
A Closed List Decides Risk.
Six specific histories, written into the regulation, decide whether a patient is high risk.
Each one is either in the record or it is not.
And the Record Was Made at Scheduling.
Family and personal history are usually gathered on the phone, months earlier, by someone who is not clinical.
That is where the money is decided.
Then the Patient Gets a Bill They Were Not Expecting.
Booked as one thing, billed as another, quoted an amount that turned out to be wrong.
That balance is disputed, delayed, and often never collected.
That Is the Work.
CareVixis manages the claims, the intervals, the appeals and the patient balances around your existing systems.
Nothing clinical changes.
The procedure happens in ten minutes. The billing was decided weeks ago.
The detail, if you want it
What the regulation says about screening tests and the six histories that define high risk, where gastroenterology practices lose money, and the questions worth asking about your own revenue.
What makes a colonoscopy a screening test?
The purpose and the patient's documented risk status, both of which exist before the procedure begins. The regulation defines colorectal cancer screening tests, which include screening colonoscopy, screening flexible sigmoidoscopy, screening computed tomography colonography and the screening fecal-occult blood test, and it defines what that stool test consists of.
It also defines high risk in a closed list rather than as a judgement. An individual at high risk is one with a close relative who has had colorectal cancer or an adenomatous polyp, a family history of familial adenomatous polyposis, a family history of hereditary nonpolyposis colorectal cancer, a personal history of adenomatous polyps, a personal history of colorectal cancer, or inflammatory bowel disease including Crohn’s Disease and ulcerative colitis. Each of those is a fact that either is in the record or is not.
What the Regulation Actually Says
['Quotations from 42 CFR Part 410, cited below. They define the screening benefit and the risk categories that govern it.', 'The high risk definition is worth reading slowly. It is an enumerated list of six histories, which means risk status is a documentation question with a right answer rather than a clinical impression.']
| Where it bites | What the published rule says |
|---|---|
| The screening tests | Colorectal cancer screening tests include screening colonoscopy, screening flexible sigmoidoscopy, the screening fecal-occult blood test and “screening computed tomography colonography”. |
| And what else may qualify | “Other tests or procedures established by a national coverage determination, and modifications to tests under this paragraph, with such frequency and payment limits as CMS determines appropriate.” |
| The stool test, defined | “A guaiac-based test for peroxidase activity, testing two samples from each of three consecutive stools”, or other tests determined through a national coverage determination. |
| High risk, first three | A close relative (sibling, parent, or child) who has had colorectal cancer or an adenomatous polyp; a family history of familial adenomatous polyposis; a family history of hereditary nonpolyposis colorectal cancer. |
| High risk, second three | A personal history of adenomatous polyps; a personal history of colorectal cancer; or inflammatory bowel disease, including Crohn’s Disease, and ulcerative colitis. |
| CT colonography, defined | “A test that uses X-rays and computers to produce images of the entire colon (including image processing and a physician’s interpretation of the results of the procedure).” |
| Who the attending is | For this provision an attending physician is a doctor of medicine or osteopathy as the Act defines it. |
CareVixis states the regulation as it is written. Frequency and payment limits are set by CMS and revised; they are not restated here.
The Most Expensive Facts Are Gathered by the Front Desk
Risk status is built from family history and personal history. Those are collected at scheduling and intake, usually by someone who is not clinical, often over the phone, months before the procedure. By the time the physician is in the room, the answer is already fixed by what was written down.
A practice can be clinically excellent and still bill the wrong benefit, because the fact that decided it was captured badly by a process nobody thinks of as revenue work. The reverse costs money too: a genuinely high risk patient recorded as average risk waits longer between procedures than the benefit allows for.
And there is the patient conversation. When a procedure booked as screening ends up billed differently, the patient receives a bill they were told they would not get. That is a collections problem and a reputational one, and it starts in the same intake form.
Decided before the procedure
- Why the patient was referred.
- Documented family history.
- Documented personal history.
- Which benefit the visit was booked under.
Decided during it
- What was found.
- What was removed.
- How the procedure was completed.
- What follow-up interval is advised.
Where a Gastroenterology Practice Loses Money
Not every practice sees all of these. They are what CareVixis expects to look at first on a GI account.
Risk status taken on the phone
Six specific histories decide it, and they are usually gathered by scheduling staff. Getting this wrong misprices the procedure in either direction.
Family history recorded loosely
The definition names a close relative, defined as a sibling, parent or child. A note reading family history of colon cancer does not establish the relationship the regulation asks about.
The patient billed a surprise
When the benefit a patient was quoted is not the benefit billed, the balance is disputed, delayed, and often written off. The cost is bigger than the difference in the claim.
Intervals applied from memory
Frequency limits differ by test and by risk status. A practice that schedules from habit rather than from the benefit will produce claims outside the interval.
Incomplete procedures
A procedure that could not be completed is a different billing question from one that was, and it is easy to handle as though nothing unusual happened.
Anaesthesia and pathology adrift
The professional services around the procedure are billed by others and can follow different assumptions about what the procedure was. Nobody reconciles them.
CareVixis publishes no denial rate, recovery rate or resolution time for gastroenterology or any other specialty, and does not suggest any practice experiences all of this. What is happening in a particular practice is a question for its own data.
Where This Fits Around What You Already Run
Where a gastroenterology claim is decided, and where CareVixis joins it.
- Referral and schedulingThe reason for the procedure and the histories that establish risk status are captured here, by whoever answers the phone.
- Intake and confirmationThe last practical moment to correct a history that was recorded loosely.
- The procedureWhat is found may change the service, but it does not change the facts that were already documented about risk.
- Claim and patient responsibilityWhich benefit, at what frequency, with what the patient was told they would owe.
- VixisIQ™CareVixis revenue intelligence reads the resulting remittance information, where appropriate data can be obtained and normalized, and looks for denial and adjustment patterns clustered on benefit and interval rather than on individual claims.
- VixisTrace™Where a claim was denied, rejected or underpaid, CareVixis claim root cause analysis works eight stages: Detect, Investigate, Identify, Correct, Prevent, Resubmit, Verify, Monitor.
- The CareVixis teamPeople take the appeal, the interval dispute and the patient balance that was never going to be collected as billed. Denials are worked the day they arrive; submitting the corrected claim or appeal the same day is the CareVixis standard.
Questions Worth Asking About Your Own Revenue
Put these to CareVixis too. In this specialty most of them point at scheduling rather than at coding.
-
Who establishes risk status, and how?
Ask which role captures the six histories and what the form actually asks them.
-
Does our intake ask about the relationship?
The definition names a sibling, parent or child. Ask whether the form captures that or just family history.
-
What are patients told they will owe?
Ask what the quote is based on, and what happens when the billed benefit differs from it.
-
Who checks the interval before scheduling?
Ask whether frequency is confirmed against the benefit or assumed from the last visit date.
-
How are incomplete procedures handled?
Ask for the process, because it is different from a completed one and is often not distinguished.
-
Do anaesthesia and pathology match our claim?
Ask who reconciles the services around the procedure with the procedure as billed.
-
How would an underpayment surface?
The claim paid, so nothing flagged it. Ask what compares payment against the contracted amount.
-
Who handles facility and professional enrollment?
Practices billing in more than one setting carry more enrollment surface than they think.
-
Is your team in the United States?
Ask where the people working your claims sit and whether you can speak to them. CareVixis does not outsource.
Using Gastroenterology? Keep It.
Keep the endoscopy and practice management systems you already run. CareVixis manages the revenue cycle around them and does not require a software change to begin.
Keeping your system is a supported outcome, not a fallback. If a practice later wants to move to the CareVixis platform, that move may be offered at no additional migration charge, and everything the patient sees still carries the practice's own name and branding.
Keep your systems. Fix the facts before the procedure, not the claim after it.
Questions Gastroenterology Practices Ask
What counts as a colorectal cancer screening test?
The regulation lists screening colonoscopy, screening flexible sigmoidoscopy, the screening fecal-occult blood test and screening computed tomography colonography, together with other tests or procedures established by a national coverage determination, with frequency and payment limits as CMS determines appropriate.
How is high risk defined?
By an enumerated list: a close relative, meaning a sibling, parent or child, who has had colorectal cancer or an adenomatous polyp; a family history of familial adenomatous polyposis; a family history of hereditary nonpolyposis colorectal cancer; a personal history of adenomatous polyps; a personal history of colorectal cancer; or inflammatory bowel disease, including Crohn's Disease and ulcerative colitis.
Why does risk status matter to billing?
Because it governs how often a screening test may be furnished. A patient recorded as average risk when the documented history makes them high risk waits longer between procedures than the benefit allows, and the reverse produces claims outside the permitted interval.
What is a screening fecal-occult blood test?
The regulation defines it as a guaiac-based test for peroxidase activity, testing two samples from each of three consecutive stools, or other tests determined by the Secretary through a national coverage determination.
Can CareVixis work aged gastroenterology balances?
Yes, as a separate arrangement charged on what is actually recovered rather than on the balance handed over. Terms are on the pricing page.
What is VixisIQ™?
VixisIQ™ is the CareVixis revenue intelligence technology. It analyses revenue cycle and remittance data to surface payment patterns, adjustments, denial and rejection patterns, payer behaviour and accounts receivable trends. What it can analyse for a particular practice depends on the data that practice is able to make available.
What is VixisTrace™?
VixisTrace™ is the CareVixis claim root cause analysis technology, covering rejected, denied, underpaid and otherwise problematic claims across eight stages. The objective is continuous improvement: identify preventable patterns, address their causes, and reduce unnecessary repeat failures.
Does CareVixis handle enrollment for GI practices?
Yes, through VixisCred™, which matters where physicians bill in both office and facility settings. See the pricing page.
Keep Gastroenterology. Add Revenue Intelligence.
By the time the scope goes in, the billing question has already been answered by a form somebody filled in weeks earlier.
Free. No obligation. No email required.
Sources
- Electronic Code of Federal Regulations, 42 CFR § 410.37 Colorectal cancer screening tests: Conditions for and limitations on coverage. Source of the list of colorectal cancer screening tests including screening computed tomography colonography and other tests established by national coverage determination, of the definition of a screening fecal-occult blood test as a guaiac-based test for peroxidase activity testing two samples from each of three consecutive stools, of the definition of screening computed tomography colonography, and of the enumerated definition of an individual at high risk for colorectal cancer. ecfr.gov. Accessed 21 September 2026.
- Electronic Code of Federal Regulations, 42 CFR § 410.37, definitions paragraph. Cited separately for the statement that an attending physician for the purposes of this provision is a doctor of medicine or osteopathy as defined in the Act, and for the provision that frequency and payment limits for additional tests are as CMS determines appropriate in consultation with appropriate organizations. ecfr.gov. Accessed 21 September 2026.
- Electronic Code of Federal Regulations, 42 CFR § 411.15 Particular services excluded from coverage, paragraph (a)(1). Cited for the exclusion of examinations performed for a purpose other than treatment or diagnosis of a specific illness, symptoms, complaint or injury, and for its express exception for colorectal cancer screening tests, which is the provision that makes a screening procedure payable at all. ecfr.gov. Accessed 21 September 2026.
These regulations are amended from time to time and the eCFR pages cited carry the current text. Frequency limits and payment amounts are published separately by CMS.
The CareVixis Model, Applied to Medical Billing for Gastroenterology Practices
The six CareVixis pillars stay consistent (Revenue Cycle, Credentialing, Technology, Communications, Operations and Growth) while the workflow adapts to this specialty's documentation, coding, payer and operational requirements. Keep the systems that work for you; CareVixis connects responsibility around them.